- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Enanta Pharmaceuticals Inc+ Add to Watchlist
ENTA:US38.6900 USD 0.1700 0.44%
As of 20:10:00 ET on 07/30/2014.
Company Profile for Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals Inc. manufactures pharmaceutical products. The Company develops, produces, and markets antibacterial drugs for hepatitis C virus, respiratory tract infections, intravenous, and oral treatments for hospital and community. Enanta Pharmaceuticals offers its products throughout the United States.
Enanta Pharmaceuticals Inc
Key Executives for Enanta Pharmaceuticals Inc (ENTA)
|Jay R LulyPresident/CEO||Nathaniel S Gardiner "Nat"Senior VP/General Counsel|
|Paul J MellettSenior VP:Finance/CFO||Timothy D OcainSenior VP:New Product Strategy|
|Yat Sun OrSenior VP:R&D/CSO||Carol MiceliDirector:Investor Relations|